Surbhi Sidana, MD | oneAMYLOIDOSISvoice

Published: Dec 19, 2019

Tags

Dr. Surbhi Sidana is an Assistant professor of medicine in the division of blood & marrow transplantation at the Stanford University Medical Center. She obtained her medical degree from Maulana Azad Medical College, New Delhi and has expertise in blood and marrow transplantation and CAR T -cell therapy. She completed her fellowships in plasma cell disorders and hematology and oncology at Mayo Clinic, Rochester and her residency in internal medicine at Cleveland Clinic.

Dr. Sidana specializes in the treatment of plasma cell disorders, such as multiple myeloma, amyloidosis and related disorders. Her research focuses on the development of novel therapeutic approaches, biomarkers and management of treatment toxicity in this field.

Representative Publications:

Impact of Consolidation Therapy Post Autologous Stem Cell Transplant in Patients With Light Chain Amyloidosis

Fifteen Year Overall Survival Rates After Autologous Stem Cell Transplantation for AL Amyloidosis

Clinical Features, Laboratory Characteristics and Outcomes of Patients With Renal Versus Cardiac Light Chain Amyloidosis

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse

First Name

Surbhi

Last Name

Sidana

Address

Department of Medicine<br>
Blood and Marrow Transplantation<br>
Stanford University Medical Center<br>
875 Blake Wilbur Dr Clinic C<br>
MC 5820